Patent Assignment
Reel/Frame 018385/0523
Release of Security Agreement
Recorded: 2006-10-12
Received: 2006-10-12
Pages: 4
Assignor
INVESTISSEMENT QUEBEC
Executed: 2006-10-05
Assignee
AMBRILIA BIOPHARMA INC.
1100, CHEMIN DU GOLF, VERDUN, QUEBEC, CAX, H3E 1H4, CANADA
Covered Properties
(9)
Lysine Based Compounds
Application:
10/902,935 →
Aromatic Derivatives as Hiv Aspartyl Protease Inhibitors
Application:
10/326,488 →
Hiv Protease Inhibitors Based on Amino Acid Derivatives
Application:
10/244,672 →
Hiv Protease Inhibitors Based on Amino Acid Derivatives
Application:
10/244,644 →
Hiv Protease Inhibitors Based on Amino Acid Derivatives
Application:
10/244,383 →
Hiv Protease Inhibitors Based on Amino Acid Derivatives
Application:
10/244,622 →
Freestanding Enclosure for Large Animals
Application:
10/245,010 →
Urea Derivatives as Hiv Aspartyl Protease Inhibitors
Application:
10/143,095 →
Hiv Protease Inhibitors Based on Amino Acid Derivatives
Application:
09/781,219 →